LENZ Therapeutics Ownership | Who Owns LENZ Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

LENZ Therapeutics Ownership Summary

LENZ Therapeutics is owned by 111.29% institutional investors, 2.65% insiders. Ra capital management is the largest institutional shareholder, holding 13.33% of LENZ shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.27% of its assets in LENZ Therapeutics shares.

LENZ Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	LENZ Therapeutics	111.29%	2.65%	-13.94%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	4.18M	13.33%	$23.74M
Alpha wave global, lp	3.61M	11.52%	$20.52M
Fmr	3.56M	11.35%	$20.21M
Versant venture management	2.66M	8.47%	$15.09M
Blackrock funding, inc. /de	2.29M	7.31%	$13.02M
Squarepoint ops	1.75M	5.57%	$9.92M
Abrdn	1.55M	4.94%	$8.79M
Millennium management	1.51M	4.81%	$8.57M
Vanguard group	1.32M	4.63%	$21.14M
Paradigm biocapital advisors lp	1.07M	3.82%	$50.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
72 investment	1.02M	11.57%	$5.78M
Versant venture management	2.66M	9.28%	$15.09M
Ally bridge group (ny)	175.36K	4.97%	$8.17M
Saturn v capital management	368.18K	3.76%	$17.15M
First light asset management	693.04K	3.04%	$32.28M
Samsara biocapital	343.01K	2.09%	$15.98M
Intrinsic edge capital management	569.71K	1.62%	$9.12M
Paradigm biocapital advisors lp	1.07M	1.42%	$50.00M
Blue owl capital lp	756.72K	0.65%	$4.30M
Rtw investments, lp	863.39K	0.50%	$40.22M

Top Buyers

Holder	Shares	% Assets	Change
First light asset management	693.04K	3.04%	693.04K
Millennium management	1.51M	0.00%	639.22K
Intrinsic edge capital management	569.71K	1.62%	569.71K
Qube research	482.19K	0.00%	482.19K
Abrdn	1.55M	0.01%	391.72K

Top Sellers

Holder	Shares	% Assets	Change
Franklin resources	-	-	-1.10M
Paradigm biocapital advisors lp	1.07M	1.42%	-643.61K
Adage capital partners gp	627.62K	0.05%	-495.12K
Granahan investment management	-	-	-431.10K
Macquarie management	-	-	-398.57K

New Positions

Holder	Shares	% Assets	Change	Value
First light asset management	693.04K	3.04%	693.04K	$32.28M
Intrinsic edge capital management	569.71K	1.62%	569.71K	$9.12M
Sixth street partners management company	172.81K	0.00%	172.81K	$981.54K
Susquehanna portfolio strategies	154.05K	0.01%	154.05K	$875.02K
Occudo quantitative strategies lp	146.38K	0.04%	146.38K	$831.42K

Sold Out

Holder	Change
Stephens consulting	-1.00
Freestone grove partners lp	-2.00
Stone house investment management	-6.00
Signaturefd	-9.00
Rise advisors	-15.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	149	-1.32%	34,891,514	5.29%	111	1.00%	89	-3.26%	34	17.24%
Mar 31, 2026	65	-61.08%	7,379,217	-78.96%	23	0.16%	44	-57.69%	10	-68.75%
Dec 31, 2025	106	-38.01%	19,426,586	-33.34%	68	0.63%	64	-46.67%	21	-12.50%
Sep 30, 2025	162	38.46%	28,801,567	16.48%	102	1.32%	115	43.75%	23	64.29%
Jun 30, 2025	116	10.48%	24,721,514	17.75%	88	1.51%	79	43.64%	14	-46.15%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	1.65M	5.27%	-
Fidelity Growth Company Fund	1.23M	3.91%	-1.52K
abrdn Healthcare Investors	1.05M	3.34%	66.42K
Vanguard Total Stock Mkt Idx Inv	819.61K	2.61%	-
Vanguard Morn Total Stk Mkt Idx Investor	819.61K	2.61%	-
Vanguard MStar Total Stk Mkt Idx Invest	819.61K	2.61%	-
C WorldWide Healthcare Select 1A	700.00K	2.23%	-
iShares Russell 2000 ETF	527.01K	1.68%	-9.41K
abrdn Life Sciences Investors	500.70K	1.60%	32.58K
PRIMECAP Odyssey Aggressive Growth	406.40K	1.30%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 27, 2026	George Jeffrey P.	-	Buy	$49.89K
Mar 27, 2026	Schimmelpennink Evert B.	President, CEO and Secretary	Buy	$251.41K
Mar 27, 2026	Chevallard Daniel R.	Chief Financial Officer	Buy	$64.28K
Nov 17, 2025	Olsson Shawn	Chief Commercial Officer	Sell	$108.41K
Nov 17, 2025	Olsson Shawn	Chief Commercial Officer	Sell	$152.61K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	3	-
2025 Q4	3	2
2025 Q3	-	29
2025 Q2	-	5

LENZ Ownership FAQ

Who Owns LENZ Therapeutics?

LENZ Therapeutics shareholders are primarily institutional investors at 111.29%, followed by 2.65% insiders and -13.94% retail investors. The average institutional ownership in LENZ Therapeutics's industry, Biotech Stocks , is 379.61%, which LENZ Therapeutics falls below.

Who owns the most shares of LENZ Therapeutics?

LENZ Therapeutics’s largest shareholders are Ra capital management (4.18M shares, 13.33%), Alpha wave global, lp (3.61M shares, 11.52%), and Fmr (3.56M shares, 11.35%). Together, they hold 36.20% of LENZ Therapeutics’s total shares outstanding.

Does Blackrock own LENZ Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LENZ Therapeutics.

Who is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested?

72 investment is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.57% of its assets in 1.02M LENZ Therapeutics shares, valued at 5.78M$.

Who is the top mutual fund holder of LENZ Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of LENZ Therapeutics shares, with 5.27% of its total shares outstanding invested in 1.65M LENZ Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools